Description: PT‑141 (bremelanotide) is a synthetic melanocortin receptor agonist that modulates sexual arousal and libido via central melanocortin pathways. Used in research to investigate sexual function, neuroendocrine signalling, and melanocortin receptor pharmacology.
Intended use: RESEARCH CHEMICAL — for in vitro testing and laboratory experimentation by qualified professionals only. Not for administration to humans or animals. This product is not a drug, food, or cosmetic and must not be misbranded, misused, or mislabeled.